Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Correlia Biosystems, a US-based immunoassay technology producer, has closed a $7m series A round involving the Regents of the University of California. The round was led by Neotribe Ventures and backed by Cota Capital alongside undisclosed additional investors. The funding is intended to facilitate the commercial launch of Correlia’s first product, a miniaturised assay known as Elisa for which applications include diagnostics, drug development and vaccines. NeoTribe Ventures will appoint an as-yet-unnamed representative to Correlia’s board of directors.
Mekonos, a US-based gene engineering-on-a-chip producer spun out of Stanford University, has closed a $4.6m round led by pharmaceutical firm Novartis. The corporate was joined by Hike Ventures, CRCM Ventures and existing investors including Elementum Ventures and Good AI Capital. The funding will go to product development to meet the needs of Mekonos’s clients.
Spirea, a UK-based antibody-drug conjugate producer spun out of University of Cambridge, has raised an undisclosed…
